| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 2.40p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.35 |
| Volume | 159,337 |
| Shares Issued | 533.35m |
| Market Cap | £12.80m |
| Beta | 1.04 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 16:23 | 28,000 @ 2.48p |
| 16:12 | 120,579 @ 2.49p |
| 09:40 | 7,758 @ 2.49p |
| 09:12 | 3,000 @ 2.35p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research